Natural Alternatives Internatio
Natural Alternatives International, Inc. operates in two segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. They offer contract manufacturing services to companies marketing nutritional supplements. The company provides various services, including product formulation, clinical study support, and regulatory compliance. They also sell beta-alanine ingredient under the CarnoSyn names. Products are manufactured in forms such as capsules, tablets, and powders. Customers include direct sales marketers, e-commerce retailers, and brick-and-mortar stores. The company was founded in 1980 and is headquartered in Carlsbad, California.
Overview
Strengths
- Price to book ratio (0.28) is lower than the sector mean (5.03).
Weaknesses
- With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Current Price to Earnings Ratio (100.00) is significantly higher than the sector mean (62.33).
- Analysts expect revenues to decline in the coming year.
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (10.87%).
- EV/EBITDA (100.00) is significantly higher than the sector mean (27.63).
- EV/EBIT (100.00) is significantly higher than the sector mean.
- The Price to Free Cash Flow ratio (100.00) is significantly higher than the sector mean.
- EBITDA Margin (0.00%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |